CDC: Early Data Suggests Potentially Severe Flu Season

December 5, 2014 Early data suggests that the current 2014-2015 flu season could be severe. The Centers for Disease Control and Prevention (CDC) urges immediate vaccination for anyone still unvaccinated this season and recommends prompt treatment with antiviral drugs for people at high risk of complications who develop flu. So far this year, seasonal influenza A H3N2 viruses have been …

Hybrid Delivery System Boosts DNA Vaccines Potential

Researchers at the University at Buffalo have developed a hybrid delivery system designed to fight cancer, HIV, flu, and other diseases Scientists from the University at Buffalo have created a novel hybrid system designed to deliver genetic antigens and elicit a strong immune response in patients, something DNA vaccines have so far failed to deliver. The hybrid, presented in the …

GSK Get The Go-ahead for Acquisition of Novartis’ Vaccines Business

Regulatory update on transaction with Novartis November 26, 2014 GlaxoSmithKline plc is today providing this update to its announcement of 22 April 2014 relating to the major three-part transaction with Novartis AG (the Original Announcement). The US Federal Trade Commission (FTC) has voted to approve GSK’s proposed acquisition of Novartis’s vaccines business (excluding influenza vaccines) and the proposed creation of …

Predicting Flu Evolution the Next Step Towards Better Flu Vaccines

  Researchers discover that individual flu strains elicit an antibody response to multiple different flu strains already experienced by a patient A global team of researchers using a new modelling system have discovered that upon infection, patients exhibit immune responses to every strain that the individual has encountered, not just the infecting strain. The strongest responses came from the strains …

Nasal Spray Flu Vaccine in Kids Can Trim Caseload And Be Cost-Effective, Especially in a Bad Season, Study Finds

With flu vaccination season upon us, the question arises, shot or nasal spray? For children, a nasal spray might be an easier option, and a new study just published in The American Journal of Pharmacy Benefits shows that if a moderate to harsh flu season is expected, it’s a cost-effective choice, too. August 31, 2014 The end of summer means …

Research suggests that vaccinations against rare strains of bird flu would be highly effective against a broad range of influenza viruses

A Universal Flu Vaccine: Could Rare Flu Strains be the Answer?

Research suggests that vaccinations against rare strains of bird flu would be highly effective against a broad range of influenza viruses A study by the Emory Vaccine Centre in Atlanta has found that exposure to rare and uncommon flu strains results in the production of broadly effective antibodies. The study thus begs the question: should the public be vaccinated against …

bioCSL Inc. Launches AFLURIA Shipping Campaign for 2014-2015 Seasonal Influenza

August 5th, 2014 bioCSL Inc. to supply U.S. Market with 16.5 Million Doses Historical reliability, coupled with dedicated commercial and production efforts, drive strong customer prebook order demand Early season deliveries will support U.S. providers’ 2014-15 vaccination needs bioCSL Inc. announced today it has commenced shipping its seasonal influenza vaccine AFLURIA(Influenza Vaccine) for the 2014-2015 flu season. U.S. providers who ordered AFLURIA may …

Microbix Biosystems Inc, an innovator of biological products and technologies, announced it has commenced a new patent litigation against Novartis, alleging infringement of its VIRUSMAX® patent in Europe

Novartis Sued by Microbix for Flu Vaccine Patent Infringement

Microbix Biosystems announced it has commenced a new patent litigation against Novartis, alleging infringement of its Virusmax patent in Europe The announcement came on July 10th, which detailed that Microbix Biosystems has commenced a new patent litigation in the Court of Dusseldorf, Germany against Novartis Vaccines and Diagnostics, alleging infringement of its VIRUSMAX patent in Europe. This is not the first time …

More Trouble in Italy for Novartis

Europe’s biggest drug maker has found themselves under investigation by the Italian police for fraud in relation to their influenza vaccines. Novartis’ plants in Siena and Origgio were searched last week by police looking for information relating to the pricing of two flu vaccines that the dug giant had sold to the Italian Health Ministry. One of the vaccines was …